1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol

C191H405N23O11 — CID 161265024

IUPAC1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol
SMILESC=CO.C=CO.C=CO.C=CO.C=CO.C=CO.CCCCCCCCCCC(O)CN(C)CCN1CCN(CCN(CCN)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCC(O)CN(CCN(CCCCCCCCCC)CCCCCCCCCC)CCN1CCN(CCC)CC1.CCCCCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCN(CCCCCCCCCC)CCNCCN1CCN(CCCC)CC1.CCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1
InChIInChI=1S/C43H90N4O.C36H77N5O.C35H75N5O2.C33H71N5O.C32H68N4.6C2H4O/c1-5-9-12-15-18-21-24-27-30-43(48)42-47(41-39-46-36-34-44(31-8-4)35-37-46)40-38-45(32-28-25-22-19-16-13-10-6-2)33-29-26-23-20-17-14-11-7-3;1-4-6-8-10-12-14-15-16-18-20-22-24-38-26-28-39-29-31-40(32-30-39)33-34-41(27-25-37-3)35-36(42)23-21-19-17-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-34(41)32-37(3)24-25-38-26-28-39(29-27-38)30-31-40(23-22-36)33-35(42)21-19-17-15-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-33(39)32-38(24-22-34-3)31-30-37-28-26-36(27-29-37)25-23-35-21-19-17-15-13-11-9-7-5-2;1-4-7-10-12-14-16-18-20-25-34(26-21-19-17-15-13-11-8-5-2)27-22-33-23-28-36-31-29-35(30-32-36)24-9-6-3;6*1-2-3/h43,48H,5-42H2,1-4H3;36-38,42H,4-35H2,1-3H3;34-35,41-42H,4-33,36H2,1-3H3;33-35,39H,4-32H2,1-3H3;33H,4-32H2,1-3H3;6*2-3H,1H2
InChIKeyVDBHWRGNOYSHAF-UHFFFAOYSA-N
MW3200.49 g/mol
LogP40.74
Rot. Bonds155

About 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol

1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol (PubChem CID 161265024) has the molecular formula C191H405N23O11 and a molecular weight of 3200.49 g/mol. Its IUPAC name is 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol.

Molecular Properties

Compound Name1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol
PubChem CID161265024
Molecular FormulaC191H405N23O11
Molecular Weight3200.49 g/mol
Exact Mass3198.18
IUPAC Name1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol
SMILESC=CO.C=CO.C=CO.C=CO.C=CO.C=CO.CCCCCCCCCCC(O)CN(C)CCN1CCN(CCN(CCN)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCC(O)CN(CCN(CCCCCCCCCC)CCCCCCCCCC)CCN1CCN(CCC)CC1.CCCCCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCN(CCCCCCCCCC)CCNCCN1CCN(CCCC)CC1.CCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1
InChIInChI=1S/C43H90N4O.C36H77N5O.C35H75N5O2.C33H71N5O.C32H68N4.6C2H4O/c1-5-9-12-15-18-21-24-27-30-43(48)42-47(41-39-46-36-34-44(31-8-4)35-37-46)40-38-45(32-28-25-22-19-16-13-10-6-2)33-29-26-23-20-17-14-11-7-3;1-4-6-8-10-12-14-15-16-18-20-22-24-38-26-28-39-29-31-40(32-30-39)33-34-41(27-25-37-3)35-36(42)23-21-19-17-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-34(41)32-37(3)24-25-38-26-28-39(29-27-38)30-31-40(23-22-36)33-35(42)21-19-17-15-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-33(39)32-38(24-22-34-3)31-30-37-28-26-36(27-29-37)25-23-35-21-19-17-15-13-11-9-7-5-2;1-4-7-10-12-14-16-18-20-25-34(26-21-19-17-15-13-11-8-5-2)27-22-33-23-28-36-31-29-35(30-32-36)24-9-6-3;6*1-2-3/h43,48H,5-42H2,1-4H3;36-38,42H,4-35H2,1-3H3;34-35,41-42H,4-33,36H2,1-3H3;33-35,39H,4-32H2,1-3H3;33H,4-32H2,1-3H3;6*2-3H,1H2
InChIKeyVDBHWRGNOYSHAF-UHFFFAOYSA-N
XLogP40.74
TPSA363.78 Ų
H-Bond Donors17
H-Bond Acceptors34
Rotatable Bonds155
Heavy Atoms225
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003200.49
LogP ≤ 540.74
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol?
The IUPAC name of 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol (CID 161265024) is 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol.
What is the SMILES notation for 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol?
The canonical SMILES for 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol is C=CO.C=CO.C=CO.C=CO.C=CO.C=CO.CCCCCCCCCCC(O)CN(C)CCN1CCN(CCN(CCN)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCC(O)CN(CCN(CCCCCCCCCC)CCCCCCCCCC)CCN1CCN(CCC)CC1.CCCCCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1.CCCCCCCCCCN(CCCCCCCCCC)CCNCCN1CCN(CCCC)CC1.CCCCCCCCCCNCCN1CCN(CCN(CCNC)CC(O)CCCCCCCCCC)CC1.
What is the InChIKey of 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol?
The InChIKey is VDBHWRGNOYSHAF-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H90N4O.C36H77N5O.C35H75N5O2.C33H71N5O.C32H68N4.6C2H4O/c1-5-9-12-15-18-21-24-27-30-43(48)42-47(41-39-46-36-34-44(31-8-4)35-37-46)40-38-45(32-28-25-22-19-16-13-10-6-2)33-29-26-23-20-17-14-11-7-3;1-4-6-8-10-12-14-15-16-18-20-22-24-38-26-28-39-29-31-40(32-30-39)33-34-41(27-25-37-3)35-36(42)23-21-19-17-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-34(41)32-37(3)24-25-38-26-28-39(29-27-38)30-31-40(23-22-36)33-35(42)21-19-17-15-13-11-9-7-5-2;1-4-6-8-10-12-14-16-18-20-33(39)32-38(24-22-34-3)31-30-37-28-26-36(27-29-37)25-23-35-21-19-17-15-13-11-9-7-5-2;1-4-7-10-12-14-16-18-20-25-34(26-21-19-17-15-13-11-8-5-2)27-22-33-23-28-36-31-29-35(30-32-36)24-9-6-3;6*1-2-3/h43,48H,5-42H2,1-4H3;36-38,42H,4-35H2,1-3H3;34-35,41-42H,4-33,36H2,1-3H3;33-35,39H,4-32H2,1-3H3;33H,4-32H2,1-3H3;6*2-3H,1H2.
What are the key properties of 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol?
1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol has a molecular weight of 3200.49 g/mol, XLogP of 40.74, 155 rotatable bonds, 17 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-[4-[2-[2-aminoethyl(2-hydroxydodecyl)amino]ethyl]piperazin-1-yl]ethyl-methylamino]dodecan-2-ol;N-[2-(4-butylpiperazin-1-yl)ethyl]-N',N'-didecylethane-1,2-diamine;1-[2-[4-[2-(decylamino)ethyl]piperazin-1-yl]ethyl-[2-(methylamino)ethyl]amino]dodecan-2-ol;1-[2-(didecylamino)ethyl-[2-(4-propylpiperazin-1-yl)ethyl]amino]dodecan-2-ol;ethenol;1-[2-(methylamino)ethyl-[2-[4-[2-(tridecylamino)ethyl]piperazin-1-yl]ethyl]amino]dodecan-2-ol is sourced from PubChem (CID 161265024), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).